IICT — 12th
Funds large-scale Swiss clinical trials addressing unmet medical needs to strengthen real-world implementation.
The SNSF Investigator Initiated Clinical Trials (IICT) programme funds large-scale randomised controlled trials (RCTs) addressing important unmet medical and societal needs that are not of commercial interest. The 12th call was launched on 27 February 2026. Trial types eligible include treatment, prevention, screening, diagnostic, quality-of-life, adaptive/platform, drug repurposing, and replicati…
Investigator-initiated, large-scale randomised controlled trials addressing unmet medical and societal needs that are not of commercial interest, typically multicentric and lasting five years.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
DocumentsGrant Work Plan Template: Work Packages, Gantt, Milestones, and Risks
Use this grant work plan template to structure work packages, tasks, owners, deliverables, Gantt timing, dependencies, and risk registers.
Submit & reportGrant Reporting Requirements: Post-Award Reports and Compliance
Learn what grant reporting requirements cover, how financial and performance reports work, what to track after an award, and how to avoid post-award compliance mistakes.
More from SNSF
All grants from this funder →BRIDGE Proof of Concept
🇨🇭SNSF · Switzerland
Funds young Swiss researchers moving research into practical demonstrations to strengthen real-world implementation.
SNSF Project Funding
🇨🇭SNSF · Switzerland
Funds Swiss individual and team science projects across strategic research areas.
Raw Materials Partnership for the Green and Digital Transition: call for European projects
🇨🇭SNSF · Switzerland
Funds Swiss researchers on European raw-materials supply and circularity projects.
Quantum Transitional Call
🇨🇭SNSF · Switzerland
Funds Swiss quantum researchers shut out of Horizon Europe's own quantum call.
BRIDGE Discovery — 10th
🇨🇭SNSF · Switzerland
Funds high-potential Swiss researchers translating ideas into practical demonstrations to strengthen real-world implementation.
Joint call for proposals with South Korea in the quantum domain
🇨🇭SNSF · Switzerland
Funds Swiss researchers on four-year joint quantum projects with South Korea.
Similar grants
Browse the directory →
Innowwide — Next
🇪🇺EUREKA · Global / Multinational
Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.
Innovation Project without Implementation Partner
🇨🇭Innosuisse · Switzerland
Funds Swiss researchers developing feasibility studies, prototypes, and testing facilities before engaging an industry partner.
Independent Living and Inclusion for Persons with Disabilities
🇪🇺European Commission · European Union
Funds person-centred health, care and technology that help people with disabilities live independently and belong in their communities.
MSCA Postdoctoral Fellowships — ISERD)
🇪🇺ISERD · Israel
Supports internationally mobile postdoctoral researchers placed in Israeli institutions to build independent research careers through EU mobility fellowships.
IHI European HealthCare Incubator Network
🇨🇦IHI JU · European Union
Funds a pan-European industry-and-academia incubator network that re-grants up to EUR 2,000,000 each to early-stage healthcare startups.
Horizon Health: Flavivirus Antibody Therapies
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one Flavivirus.